ORXOY

Orexo AB

 
Sponsored ADR (1 ADS : 1 Ordinary) International Reporting
OTCQX International OTCQX Advisor: Citi
Verified Company Profile 7/25/2017
Contact Info
  • P.O. Box 303
  • Virdings alle 32A
  • Stockholm, Uppsala SE-751 05
  • Sweden

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: OMX Nordic Exchange Stockholm
Audited Financials Audited
Latest Report Sep 30, 2017 Quarterly Report
CIK 0001585063
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Sweden
Year of Inc. 1995
Employees 104 a/o Sep 30, 2016
Company Officers/Contacts
Nikolaj Sorensen CEO
Robert A. DeLuca President, Subsidiary
Henrik Juuel EVP, CFO
Company Directors
Martin Nicklasson Chairman
David Colpman
Raymond G. Hill
Staffan Lindstrand
Kristina Schauman
Michael Shalmi
Company Notes
  • Sponsored for OTCQX by Citi on 11/13/2013
Service Providers
OTCQX Advisor
Citi
388 Greenwich St.
New York, NY, 10013
USA

Accounting/Auditing Firm
Ernst & Young LLP
11th km National Road Athens-Lamia
Athens, Greece

Legal Counsel
Not Available
Investor Relations Firm
Not Available
ORXOY Security Details Other Company Securities
Share Structure
Market Value1 $152,664,966 a/o Dec 15, 2017
Authorized Shares Not Available
Outstanding Shares 34,539,585 a/o Jun 30, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Citi
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
ORX - OMX Nordic Exchange Stockholm - Qualified
Short Selling Data
Short Interest 50 (-51.92%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security